Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
WR279396
National Institutes of Health
Create Alert
Related topics
Related topics
1 relation
Broader (1)
Aminoglycosides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Early Curative Applications of the Aminoglycoside WR279396 on an Experimental Leishmania major-Loaded Cutaneous Site Do Not Impair the Acquisition of Immunity
H. Lecoeur
,
P. Buffet
,
G. Milon
,
T. Lang
Antimicrobial Agents and Chemotherapy
2009
Corpus ID: 5839542
ABSTRACT Topical therapy is an attractive approach for the treatment of Leishmaniamajor cutaneous leishmaniasis (CL). WR279396…
Expand
2007
2007
Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL/6 Model
H. Lecoeur
,
P. Buffet
,
+4 authors
T. Lang
PLoS neglected tropical diseases
2007
Corpus ID: 5554422
Background Because topical therapy is easy and usually painless, it is an attractive first-line option for the treatment of…
Expand
Highly Cited
2002
Highly Cited
2002
Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.
J. Soto
,
J. T. Toledo
,
+6 authors
M. Grogl
The American journal of tropical medicine and…
2002
Corpus ID: 12611865
We studied the efficacy of WR279396, a topical formulation of aminoglycosides that cures 100% of cutaneous leishmaniasis lesions…
Expand
2002
2002
Topical Treatment of Cutaneous Leishmaniasis with WR279396: A Phase II Study in the Old World
P. Buffet
2002
Corpus ID: 70985489
Abstract : Action was taken in three directions: 1) Coordination between sites. The French Study Coordinator visited the Tunisian…
Expand
1995
1995
Four Week Toxicity Study of WR279396 After Daily Dermal Application in CD (registered trademark) Rats
B. S. Levine
1995
Corpus ID: 68658949
Abstract : This study evaluated the toxicity of WR279396 (Iowa Formulation 232 containing 15% paromomycin sulfate and 0.5…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE